Longevity Health Holdings Inc
NASDAQ:XAGE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Longevity Health Holdings Inc
NASDAQ:XAGE
|
US |
|
F
|
FenixOro Gold Corp
CNSX:FENX
|
CA |
Income Statement
Earnings Waterfall
Longevity Health Holdings Inc
Income Statement
Longevity Health Holdings Inc
| Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||
| Interest Expense |
1
|
0
|
0
|
1
|
2
|
2
|
2
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
4
N/A
|
0
N/A
|
4
N/A
|
4
+0%
|
0
-99%
|
0
+53%
|
1
+1 015%
|
1
+88%
|
|
| Gross Profit | ||||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
0
|
0
|
(2)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
2
N/A
|
0
N/A
|
0
N/A
|
2
N/A
|
0
-99%
|
0
+59%
|
0
+613%
|
1
+93%
|
|
| Operating Income | ||||||||||||||||
| Operating Expenses |
(0)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(9)
|
(5)
|
(16)
|
(16)
|
(9)
|
(5)
|
(5)
|
(6)
|
|
| Selling, General & Administrative |
(0)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(7)
|
(3)
|
(9)
|
(9)
|
(6)
|
(4)
|
(5)
|
(5)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
(5)
|
(5)
|
(3)
|
(1)
|
(1)
|
(1)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Operating Income |
(0)
N/A
|
(1)
-115%
|
(1)
-28%
|
(1)
-2%
|
(2)
-25%
|
(2)
-14%
|
(3)
-46%
|
(7)
-156%
|
(5)
+26%
|
(12)
-133%
|
(14)
-12%
|
(9)
+33%
|
(5)
+46%
|
(5)
-3%
|
(6)
-13%
|
|
| Pre-Tax Income | ||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
1
|
2
|
4
|
6
|
9
|
(0)
|
6
|
4
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
0
|
(1)
|
(0)
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(11)
|
(10)
|
(23)
|
(25)
|
(16)
|
(6)
|
(4)
|
(1)
|
|
| Pre-Tax Income |
(0)
N/A
|
(1)
-161%
|
(1)
-8%
|
(0)
+71%
|
1
N/A
|
2
+240%
|
3
+39%
|
(9)
N/A
|
(16)
-76%
|
(31)
-88%
|
(35)
-13%
|
(26)
+25%
|
(11)
+59%
|
(9)
+19%
|
(7)
+16%
|
|
| Net Income | ||||||||||||||||
| Tax Provision |
0
|
0
|
(0)
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(0)
|
(1)
|
(1)
|
(0)
|
0
|
1
|
2
|
(10)
|
(16)
|
(31)
|
(35)
|
(26)
|
(11)
|
(9)
|
(7)
|
|
| Net Income (Common) |
(0)
N/A
|
(1)
-161%
|
(1)
-40%
|
(0)
+78%
|
0
N/A
|
1
+524%
|
2
+51%
|
(10)
N/A
|
(16)
-55%
|
(31)
-90%
|
(34)
-12%
|
(26)
+25%
|
(10)
+59%
|
(9)
+17%
|
(7)
+16%
|
|
| EPS (Diluted) |
-0.51
N/A
|
-1.34
-163%
|
-1.87
-40%
|
-0.42
+78%
|
0.32
N/A
|
2.04
+538%
|
2.2
+8%
|
-13.48
N/A
|
-43.88
-226%
|
-40.04
+9%
|
-49.5
-24%
|
-36.7
+26%
|
-14.56
+60%
|
-8.67
+40%
|
-5.93
+32%
|
|